ProPhase Labs, Inc. Increase (Decrease) in Other Operating Assets
ProPhase Labs, Inc. (PRPH) reported Increase (Decrease) in Other Operating Assets of $0 for the 12-month period ending 2025-12-31, per its 10-K filed 2026-06-01.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherOperatingAssets · last filed 2026-06-01
- ProPhase Labs, Inc. increase (decrease) in other operating assets for the quarter ending 2025-12-31 was $0.00, a 100.00% decline year-over-year.
- ProPhase Labs, Inc. increase (decrease) in other operating assets for the quarter ending 2025-09-30 was $0.00.
- ProPhase Labs, Inc. increase (decrease) in other operating assets for the quarter ending 2025-06-30 was $0.00.
- ProPhase Labs, Inc. increase (decrease) in other operating assets for the quarter ending 2025-03-31 was $0.00.
- ProPhase Labs, Inc. increase (decrease) in other operating assets for fiscal 2025 was $0.00.
- ProPhase Labs, Inc. increase (decrease) in other operating assets for fiscal 2024 was -$853.00K.
- ProPhase Labs, Inc. increase (decrease) in other operating assets for fiscal 2023 was $0.00.
| Period end | Increase (Decrease) in Other Operating Assets 3 month | Increase (Decrease) in Other Operating Assets 6 month | Increase (Decrease) in Other Operating Assets 9 month | Increase (Decrease) in Other Operating Assets 9 month as first filed | Increase (Decrease) in Other Operating Assets 12 month |
|---|---|---|---|---|---|
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-06-01 | $0.00 derived: sum of 2 quarters · filed 2026-06-01 | $0.00 derived: sum of 3 quarters · filed 2026-06-01 | $0.00 10-K · filed 2026-06-01 | |
| 2025-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-19 | $0.00 derived: sum of 2 quarters · filed 2025-11-19 | $0.00 10-Q · filed 2025-11-19 | $1.00K derived: sum of 4 quarters · filed 2026-06-01 | |
| 2025-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-13 | $0.00 10-Q · filed 2025-08-13 | $1.00K derived: sum of 3 quarters · filed 2026-06-01 | -$6.00K derived: sum of 4 quarters · filed 2026-06-01 | |
| 2025-03-31 | $0.00 10-Q · filed 2025-05-20 | $1.00K derived: sum of 2 quarters · filed 2026-06-01 | -$6.00K derived: sum of 3 quarters · filed 2026-06-01 | -$6.00K derived: sum of 4 quarters · filed 2026-06-01 | |
| 2024-12-31 | $1.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-06-01 | -$6.00K derived: sum of 2 quarters · filed 2026-06-01 | -$6.00K derived: sum of 3 quarters · filed 2026-06-01 | -$853.00K 10-K · filed 2026-06-01 | |
| 2024-09-30 | -$7.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-19 | -$7.00K derived: sum of 2 quarters · filed 2025-11-19 | -$854.00K 10-Q · filed 2025-11-19 | -$853.00K 10-Q · filed 2024-11-13 | -$854.00K derived: sum of 4 quarters · filed 2025-11-19 |
| 2024-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-13 | -$847.00K 10-Q · filed 2025-08-13 | -$847.00K derived: sum of 3 quarters · filed 2025-08-13 | -$847.00K derived: sum of 4 quarters · filed 2025-08-13 | |
| 2024-03-31 | -$847.00K 10-Q · filed 2025-05-20 | -$847.00K derived: sum of 2 quarters · filed 2025-05-20 | -$847.00K derived: sum of 3 quarters · filed 2025-05-20 | -$847.00K derived: sum of 4 quarters · filed 2025-05-20 | |
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-04-01 | $0.00 derived: sum of 2 quarters · filed 2025-04-01 | $0.00 derived: sum of 3 quarters · filed 2025-04-01 | $0.00 10-K · filed 2025-04-01 | |
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-13 | $0.00 derived: sum of 2 quarters · filed 2024-11-13 | $0.00 10-Q · filed 2024-11-13 | ||
| 2023-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-14 | $0.00 10-Q · filed 2024-08-14 | |||
| 2023-03-31 | $0.00 10-Q · filed 2024-05-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| Processa Pharmaceuticals, Inc. (PCSA) | United States | $0.005B | |
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B | |
| Dermata Therapeutics, Inc. (DRMA) | United States | $0.005B | -0.62 |
| REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH) | United States | $0.005B | |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |